Citryll
Latest round
- Series B
Last raised
- Dec 2024
Total raised
- $107M
Investors
- 10
About Citryll
V. specializes in creating targeted therapies for serious medical conditions.V. offers advanced therapeutic products, particularly focusing on antibody drug conjugates designed to treat severe diseases. Their product lineup is tailored for healthcare providers and patients, emphasizing efficacy and safety.The company generates revenue through strategic partnerships and collaborations in the pharmaceutical industry.V. plans to launch new therapeutic products aimed at specific disease targets in the upcoming years. The company is also exploring expansion into new European markets and North America by 2025.00 mn will support these initiatives, allowing for accelerated research and market entry efforts.
Who invested in Citryll
10 investors across 2 rounds
See all investors in Citryll
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Citryll
Who invested in Citryll?
Citryll has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Citryll raised?
Citryll has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Citryll last raise money?
Citryll's most recent round on record is a Series B, in Dec 2024.
What does Citryll do?
Citryll is a pharmaceuticals company.
Where is Citryll headquartered?
Citryll is headquartered in Netherlands.
Which VCs invest in companies like Citryll?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Citryll's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Citryll? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.